Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer
Genes, Chromosomes and Cancer · 2026-06 · 65 (6)
DOI: 10.1002/gcc.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 14.06.2026. Verfasst von Anaëlle Isnard und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHU Bordeaux, Tumor Biology and Tumor Bank Laboratory, Pessac, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Chromosomes, Human, Y. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Alterations of the Y chromosome are frequent events in solid tumors, yet their biological and clinical significance remains incompletely understood. In colorectal cancer (CRC), recent studies have suggested context‐dependent roles of Y‐linked genes in tumor progression, while the impact of tumor‐associated loss of the Y chromosome (LoY) in metastatic disease has not been clearly established.
Methods
We retrospectively analyzed primary tumor samples from 91 male patients with metastatic CRC treated at a single institution. Tumor LoY status was assessed using a droplet digital PCR–based assay. Associations between LoY, clinicopathological characteristics, KRAS/BRAF mutation status, and patient outcomes, including progression‐free survival (PFS) and overall survival (OS), were evaluated. Exploratory analyses of TCGA‐COAD/READ data were performed using chromosome Y copy‐number segment data, mutation data, and survival information.
Results
Tumor LoY was detected in 46 cases (50.5%) and was more frequent in rectal cancers ( p = 0.038). LoY was not associated with age, microsatellite instability status, KRAS or BRAF mutations. While PFS did not differ according to LoY status, OS was longer in patients with LoY‐positive tumors ( p = 0.046). In multivariable analysis, LoY showed a non‐significant trend toward improved OS (HR = 0.52, 95% CI: 0.25–1.10; p = 0.07). In exploratory TCGA analyses, chromosome Y copy‐number signal did not significantly differ between colon and rectal cancers, but lower chromosome Y signal was associated with worse OS, particularly in TCGA‐COAD after adjustment for age and KRAS / BRAF status.
Conclusions
LoY is a frequent chromosomal alteration in metastatic CRC and appears enriched in rectal primary tumors in our cohort. Its association with clinical outcome may depend on disease stage, molecular background, and analytical methodology. These findings support further investigation of Y chromosome loss as a context‐dependent biomarker in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU Bordeaux, Tumor Biology and Tumor Bank Laboratory, Pessac, France.
- BRIC (BoRdeaux Institute of Oncology), INSERM, University of Bordeaux, Bordeaux, France.
- Oncology Unit, Haut Lévêque Hospital, University Hospital Center of Bordeaux, Pessac, France.
- CHU Bordeaux, Colorectal Digestive Surgery Department, Bordeaux, France.
- CHU Bordeaux, Biochemistry Laboratory, Bordeaux, France.
- CHU Bordeaux, Hematology Laboratory, Bordeaux, France.
ORCID-Profile: Olivier Mansier, Samuel Amintas
Zitieren
APA
Isnard, A., Decraecker, M., Fernandez, B., Smith, D., Dubus, P., Dabernat, S., Mansier, O., & Amintas, S. (2026). Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer. Genes, Chromosomes and Cancer, 65(6). https://doi.org/10.1002/gcc.70147
Vancouver
Isnard A, Decraecker M, Fernandez B, Smith D, Dubus P, Dabernat S, et al. Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer. Genes, Chromosomes and Cancer. 2026;65(6). doi:10.1002/gcc.70147
BibTeX
@article{Isnard2026,
author = {Isnard, Anaëlle and Decraecker, Marie and Fernandez, Benjamin and Smith, Denis and Dubus, Pierre and Dabernat, Sandrine and Mansier, Olivier and Amintas, Samuel},
title = {Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer},
journal = {Genes, Chromosomes and Cancer},
year = {2026},
volume = {65},
number = {6},
doi = {10.1002/gcc.70147}
}
EUVIMED